ECSP20057951A - Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular - Google Patents

Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular

Info

Publication number
ECSP20057951A
ECSP20057951A ECSENADI202057951A ECDI202057951A ECSP20057951A EC SP20057951 A ECSP20057951 A EC SP20057951A EC SENADI202057951 A ECSENADI202057951 A EC SENADI202057951A EC DI202057951 A ECDI202057951 A EC DI202057951A EC SP20057951 A ECSP20057951 A EC SP20057951A
Authority
EC
Ecuador
Prior art keywords
granular composition
production method
dissolution property
property improvement
granular
Prior art date
Application number
ECSENADI202057951A
Other languages
English (en)
Inventor
Rie Yamada
Toshinori Tanaka
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of ECSP20057951A publication Critical patent/ECSP20057951A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)

Abstract

Se proporciona un método de producción para una composición granular en el que se mejora la propiedad de disolución de 2–{4–[N–(5,6–difenilpiradin–2–il)–N–isopropilamino]butiloxi}–N–(metilsulfonil)acetamida. El método de producción para una composición granular incluye una etapa de moldeo por compresión de una mezcla obtenida por mezcla de 2–{4–[N–(5,6–difenilpiradin–2–il)–N–isopropilamino]butiloxi}–N–(metilsulfonil)acetamida y al menos uno o más excipientes seleccionados del grupo que consiste en un alcohol de azúcar, un almidón y un sacárido, obteniendo así un material moldeado por compresión.
ECSENADI202057951A 2018-02-21 2020-09-17 Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular ECSP20057951A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018029093 2018-02-21

Publications (1)

Publication Number Publication Date
ECSP20057951A true ECSP20057951A (es) 2020-10-30

Family

ID=67687749

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202057951A ECSP20057951A (es) 2018-02-21 2020-09-17 Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular

Country Status (21)

Country Link
US (1) US20200397700A1 (es)
EP (1) EP3756670A4 (es)
JP (2) JP7430629B2 (es)
KR (1) KR20200123447A (es)
CN (1) CN112055591A (es)
AR (1) AR114399A1 (es)
AU (1) AU2019225516A1 (es)
BR (1) BR112020016230A2 (es)
CA (1) CA3091584A1 (es)
CL (1) CL2020002129A1 (es)
CO (1) CO2020011034A2 (es)
EC (1) ECSP20057951A (es)
IL (1) IL276732A (es)
MA (1) MA51913A (es)
MX (1) MX2020008695A (es)
PE (1) PE20210448A1 (es)
PH (1) PH12020551285A1 (es)
RU (1) RU2020130411A (es)
SG (1) SG11202007967YA (es)
TW (1) TW201936175A (es)
WO (1) WO2019163822A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220401441A1 (en) * 2019-10-23 2022-12-22 Actelion Pharmaceuticals Ltd Pharmaceutical composition comprising selexipag
JP6989064B1 (ja) * 2020-04-10 2022-01-05 日本新薬株式会社 固形製剤及びその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2654197B2 (ja) * 1989-09-25 1997-09-17 三菱電機株式会社 スターリングエンジンの圧縮機駆動装置
WO2002024168A1 (fr) * 2000-09-25 2002-03-28 Nippon Shinyaku Co., Ltd. Procede de production d'une dispersion solide medicinale
TWI316055B (es) 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
ES2312741T3 (es) * 2003-05-06 2009-03-01 Gumlink A/S Procedimiento para producir granulos de goma de mascar y granulos de goma comprimidos, y un equipo para granular goma de mascar.
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents
KR20240090717A (ko) * 2009-06-26 2024-06-21 니뽄 신야쿠 가부시키가이샤 결정
JP6825574B2 (ja) 2015-12-02 2021-02-03 日本新薬株式会社 ２−｛４−［ｎ−（５，６−ジフェニルピラジン−２−イル）−ｎ−イソプロピルアミノ］ブチルオキシ｝−ｎ−（メチルスルホニル）アセトアミドを含有する医薬組成物
WO2017121806A1 (en) * 2016-01-15 2017-07-20 Sandoz Ag Pharmaceutical composition of selexipag

Also Published As

Publication number Publication date
EP3756670A1 (en) 2020-12-30
RU2020130411A3 (es) 2022-03-21
JP2023182650A (ja) 2023-12-26
MX2020008695A (es) 2020-09-25
CO2020011034A2 (es) 2020-12-10
AR114399A1 (es) 2020-09-02
CN112055591A (zh) 2020-12-08
JPWO2019163822A1 (ja) 2021-02-04
SG11202007967YA (en) 2020-09-29
PE20210448A1 (es) 2021-03-08
TW201936175A (zh) 2019-09-16
CA3091584A1 (en) 2019-08-29
EP3756670A4 (en) 2021-11-03
PH12020551285A1 (en) 2021-05-31
US20200397700A1 (en) 2020-12-24
JP7430629B2 (ja) 2024-02-13
CL2020002129A1 (es) 2021-02-05
KR20200123447A (ko) 2020-10-29
AU2019225516A1 (en) 2020-10-08
RU2020130411A (ru) 2022-03-21
MA51913A (fr) 2020-12-30
WO2019163822A1 (ja) 2019-08-29
IL276732A (en) 2020-09-30
BR112020016230A2 (pt) 2020-12-08

Similar Documents

Publication Publication Date Title
ECSP20057951A (es) Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular
BRPI0707044B8 (pt) comprimido matricial insolúvel em água e processo de fabricação de comprimidos matriciais
BR112019001528A8 (pt) novas formulações de comprimidos de cannabus e composições e métodos de produção do mesmo
AR111570A1 (es) Composición farmacéutica que comprende selexipag
BR112017000006A2 (pt) processo para a produção de um leite de cal apagada de grande finura e leite de cal de grande finura assim obtido".
BR112019006488A2 (pt) artigos formados de materiais de base de polpa com liberação de aroma modulada
PH12017501933A1 (en) Bromodomain inhibitor
UY38429A (es) Procesos, métodos, y sistemas para explosión celular quimio-mecánica y productos sólidos y líquidos
BR112018068144A2 (pt) métodos e composições para maior produção de rna de fita dupla
ECSP22040921A (es) Composición farmacéutica que comprende selexipag
AR069590A1 (es) Procedimiento y tricotosa circular para la fabricacion de un articulo de tejido de punto a partir de un material de fibra no retorcido
BR112018069325A2 (pt) composições e métodos de utilização destas em fundição com areia
BR112014019682A8 (pt) Processo para o preparo de composições ou sistemas de cimento ou argamassas ou concreto, produto, composições de cimento, uso de dita junção, produtos ou elementos de cimento, e uso de tais produtos ou elementos de cimento
AR078750A1 (es) Composicion farmaceutica para la administracion oral
AR109859A1 (es) Inhibidor de bromodominio
ES2545371T3 (es) Procedimiento para la producción de un material de construcción
RU2017130661A (ru) Сырьевая смесь для изготовления керамзита
BR112018006766A2 (pt) tampões autossuportantes e outras estruturas para uso em produção de plantas
RU2538025C1 (ru) Шихта для производства пористого заполнителя
BR112022008288A2 (pt) Processo para a produção de um produto alimentício de massa por extrusão através de uma pastilha feita de resina de poliacetal e produto relacionado
AR101700A1 (es) Mezcla para la fabricación de un producto cerámico refractario, procedimiento para la aplicación de una masa para fundición inyectada o masa para fundición sobre una superficie, procedimiento para la fabricación de un producto cerámico refractario y un producto cerámico refractario
BR112022000514A2 (pt) Composição de sulfeto de polifenileno/poliamida, uso do copolímero em bloco de estireno-dieno hidrogenado, processo para preparar uma mistura que compreende sulfeto de polifenileno e poliamida e artigo
RU2514479C1 (ru) Сырьевая смесь для производства керамзита
RU2590237C1 (ru) Сырьевая смесь для производства керамзита
BRPI0802983A2 (pt) sistema para troca rápida de dispositivos pneumáticos para expulsão de barras de sabão da matriz